Role of CD8 T-cell-mediated autoimmune diseases of the central nervous system

Critical Reviews in Immunology

Volumn 30, Issue 4, 2010, Pages 311-326

  Deckert, Martina ^a   Sanchez Ruiz, Monica ^a   Brunn, Anna ^a   Schlüter, Dirk ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

astrocyte; autoimmunity; CD8 T cells; CNS; infection; Listeria monocytogenes; molecular mimicry; neuron

Indexed keywords

AUTOANTIGEN; CYTOKINE; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR; EPITOPE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL POPULATION; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE ASSOCIATION; ENCEPHALOMYELITIS; EPSTEIN BARR VIRUS INFECTION; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR MIMICRY; NEUROLOGIC DISEASE;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR MIMICRY;

EID: 77954909027     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v30.i4.10     Document Type: Review

References (99)

1. Munz C, Lunemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol. 2009 Apr;9(4):246-258
2. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med. 2007 Nov 26;204(12):2899-2912
3. Wiestler OD, Deckert-Schluter M, H.P. H. Immunologische Aspekte bei Erkrankungen des ZNS. In: Ganten D, Ruckpaul K, editors. Hnadbuch der Molekularen Medizin Erkrankungen des Zentralnervensystems. Berlin: Springer; 1999. p. 3-28.
4. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis. 1997 Dec;176 Suppl 2:S92-8.
5. Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel RM. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med. 1997 Apr 7;185(7):1241-1251
6. Richter K, Hausmann J, Staeheli P. Interferon-gamma prevents death of bystander neurons during CD8 T cell responses in the brain. Am J Pathol. 2009 May;174(5):1799-1807
7. McGavern DB, Truong P. Rebuilding an immune- mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells. J Immunol. 2004 Oct 15;173(8):4779-4790
8. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW. Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol. 2008;26:171-203.
9. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995 Mar 10;80(5):695-705.
10. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J. 1998 Oct;12(13):1255-1265
11. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985 Nov 29;230(4729):1043-1045
12. Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest. 2001 Jul;108(2):311-318
13. Croxford JL, Ercolini AM, Degutes M, Miller SD. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus. Eur J Immunol. 2006 Oct;36(10):2671-2680
14. Croxford JL, Olson JK, Anger HA, Miller SD. Initiation and exacerbation of autoimmune demyelina- tion of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis ofmultiple sclerosis. J Virol. 2005 Jul;79(13):8581-8590
15. Sandalova T, Michaelsson J, Harris RA, Odeberg J, Schneider G, Karre K, Achour A. A structural basis for CD8+ T cell-dependent recognition of non-homologous peptide ligands: implications for molecular mimicry in autoreactivity. J Biol Chem. 2005 Jul 22;280(29):27069-27075
16. Fiorillo MT, Ruckert C, Hulsmeyer M, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B. Allele- dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem. 2005;280(4):2962-2971
17. Evans CF, Horwitz MS, Hobbs MV, Oldstone MB. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med. 1996 Dec 1;184(6):2371-2384
18. Sanchez-Ruiz M, Wilden L, Muller W, Stenzel W, Brunn A, Miletic H, Schluter D, Deckert M. Molecular mimicry between neurons and an intracerebral pathogen induces a CD8 T cell-mediated autoimmune disease. J Immunol. 2008 Jun 15;180(12):8421-8433
19. Ransohoff RM. Immunology: In the beginning. Nature. 2009 Nov 5;462(7269):41-42
20. Bartholomaus I, Kawakami N, Odoardi F, Schlager C, Miljkovic D, Ellwart JW, Klinkert WE, Flugel- Koch C, Issekutz TB, Wekerle H, FlUgel A. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature. 2009 Nov 5;462(7269):94-98
21. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F. C-C chemokine receptor 6-regulated entry ofTH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009 May;10(5):514-523
22. Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiol- ogy of neurological disease. Acta Neuropathol. 2009 Jan;117(1):1-14.
23. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends Immunol. 2007 Jan;28(1):12-18
24. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci. 1999 Oct;11(10):3648-3658
25. Andersson PB, Perry VH, Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 1992;48(1):169-186
26. Bradl M, Bauer J, Flugel A, Wekerle H, Lassmann H. Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord. Am J Pathol. 2005 May;166(5):1441-1450
27. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron- mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med. 2006 May;12(5):518-525
28. Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord. 2008 May;46(5):364-371
29. Schluter D, Kaefer N, Hof H, Wiestler OD, Deckert-Schluter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol. 1997 Mar;150(3):1021-1035
30. Neumann H, Misgeld T, Matsumuro K, Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5779-5784
31. Deckert M, Sedgwick JD, Fischer E, Schluter D. Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction. Acta Neuropathol. 2006 Jun;111(6): 548-558
32. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN, Sedgwick JD. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000 Dec 1; 290(5497):1768-1771
33. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol. 2006 Apr;7(4):354-359
34. Murphy S, Pearce B, Jeremy J, Dandona P. Astrocytes as eicosanoid-producing cells. Glia. 1988;1(4):241-245
35. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38:97-120.
36. Bernardo A, Levi G, Minghetti L. Role of the peroxi- some proliferator-activated receptor-gamma (PPAR- gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur J Neurosci. 2000 Jul;12(7):2215-2223
37. Levi G, Minghetti L, Aloisi F. Regulation of pros- tanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie. 1998 Nov;80(11):899-904.
38. Schluter D, Oprisiu SB, Chahoud S, Weiner D, Wiestler OD, Hof H, Deckert-Schluter M. Systemic immunization induces protective CD4+ and CD8+ T cell-mediated immune responses in murine Listeria monocytogenes meningoencephalitis. Eur J Immunol. 1995 Aug;25(8):2384-2391
39. Galea I, Bernardes-Silva M, Forse PA, van Rooijen N, Liblau RS, Perry VH. An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med. 2007 Sep 3;204(9):2023-2030
40. Deckert-Schluter M, Schluter D, Hof H, Wiestler OD, Lassmann H. Differential expression of ICAM- 1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultra- structural immunohistochemical study. J Neuropathol Exp Neurol. 1994 Sep;53(5):457-468
41. Hoftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H. Expression of major histocompatibil- ity complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 2004 Jan;14(1):43-50.
42. Schluter D, Chahoud S, Lassmann H, Schumann A, Hof H, Deckert-Schluter M. Intracerebral targets and immunomodulation of murine Listeria monocytogenes meningoencephalitis. J Neuropathol Exp Neurol. 1996 Jan;55(1):14-24.
43. Schluter D, Deckert M, Hof H, Frei K. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect Immun. 2001 Dec;69(12):7889-7893
44. Ahmed R, Stevens JG. Viral persistence. In: Fields BN, Knipe DM, editors. Field's virology. New York: Raven Press; 1990. p. 241-266
45. Esiri MM, Kennedy PGE. Virus diseases. In: Adams JH, Duchen LW, editors. Greenfield's neuropathology. 5 ed. New York: Oxford University Press; 1992. p. 335-399
46. Schlitt M, Chronister RB, Whitley RJ. Pathogenesis and pathophysiology of viral infections of teh central nervous system. In: Scheld W, editor. Infections of the central nervous system. New York: Raven Press; 1991. p. 7-18.
47. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol. 2005 Sep;79(17):11457-11466
48. Patterson CE, Daley JK, Echols LA, Lane TE, Rall GF. Measles virus infection induces chemokine synthesis by neurons. J Immunol. 2003 Sep 15;171(6):3102-3109
49. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003 Feb;77(4):2578-2586
50. Strack A, Schluter D, Asensio VC, Campbell IL, Deckert M. Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors. Glia. 2002 Dec;40(3):372-377
51. Deckert-Schluter M, Bluethmann H, Rang A, Hof H, Schluter D. Crucial role ofTNF receptor type 1 (p55), but not ofTNF receptor type 2 (p75), in murine toxo plasmosis. J Immunol. 1998 Apr 1;160(7):3427-3436
52. Deckert-Schluter M, Rang A, Weiner D, Huang S, Wiestler OD, Hof H, Schluter D. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab Invest. 1996 Dec;75(6):827-841
53. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science. 1995 Jul 28;269(5223):549-552
54. Shrestha B, Diamond MS. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol. 2007 Nov;81(21):11749-11757
55. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med. 1996 Oct 1;184(4):1513-1518
56. Grosjean MB, Lenzlinger PM, Stahel PF, Yatsiv I, Shohami E, Trentz O, Kossmann T, Morganti-Kossmann MC. Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: relationship with neuronal cell death and inflammatory mediators. Histol Histopathol. 2007 Mar;22(3):235-250
57. Matsuyama T, Hata R, Tagaya M, Yamamoto Y, Nakajima T, Furuyama J, Wanaka A, Sugita M. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 1994 Sep 19;657(1-2):342-346
58. Medana IM, Gallimore A, Oxenius A, Martinic MM, Wekerle H, Neumann H. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur J Immunol. 2000 Dec;30(12):3623-3633
59. Mori I, Goshima F, Imai Y, Kohsaka S, Sugiyama T, Yoshida T, Yokochi T, Nishiyama Y, Kimura Y. Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis. J Gen Virol. 2002 Sep;83(Pt 9):2109-2116
60. van Lint AL, Kleinert L, Clarke SR, Stock A, Heath WR, Carbone FR. Latent infection with herpes simplex virus is associated with ongoing CD8+ T-cell stimulation by parenchymal cells within sensory ganglia. J Virol. 2005 Dec;79(23):14843-14851
61. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science. 2008 Oct 10;322(5899):268-271
62. Baur K, Rauer M, Richter K, Pagenstecher A, Gotz J, Hausmann J, Staeheli P. Antiviral CD8 T cells recognize borna disease virus antigen transgenically expressed in either neurons or astrocytes. J Virol. 2008 Mar;82(6):3099-3108
63. Gay FW, Drye TJ, Dick GW, Esiri MM. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain. 1997 Aug;120 ( Pt 8):1461-1483
64. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, SchrOder R, Deckert M, Schmidt S, Ravid R, Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipula- tion and single cell polymerase chain reaction. J Exp Med. 2000 Aug 7;192(3):393-404.
65. Panegyres PK, Reading MC, Esiri MM. The inflammatory reaction of paraneoplastic ganglionitis and encephalitis: an immunohistochemical study. J Neurol. 1993 Feb;240(2):93-97
66. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol. 2002 Mar;51(3):311-318
67. Booss J, Esiri MM, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci. 1983 Dec; 62(1-3):219-232
68. Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplas- tic encephalomyelitis. Neurology. 1998 Oct;51(4): 1146-1150
69. Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, Meinl E, Hohlfeld R, Dornmair K. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain. 2007 Nov;130(Pt 11):2789-2799
70. Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomeso- dermin. Science. 2008 Jul 18;321(5887):408-411
71. Friese MA, Fugger L. Pathogenic CD8(+) T cells in multiple sclerosis. Ann Neurol. 2009 Aug;66(2): 132-141
72. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, Desbois S, Waisman A, Lassmann H, Liblau RS, Mars LT. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol. 2008 Aug 1;181(3):1617-1621
73. Ford ML, Evavold BD. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol. 2005 Jan;35(1):76-85.
74. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med. 2001 Sep 3;194(5):669-676
75. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, Raine CS. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol. 2001 Jun 15;166(12):7579-7587
76. Tsunoda I, Kuang LQ, Kobayashi-Warren M, Fujinami RS. Central nervous system pathology caused by auto- reactive CD8+ T-cell clones following virus infection. J Virol. 2005 Dec;79(23):14640-14646
77. Howe CL, Ure D, Adelson JD, LaFrance-Corey R, Johnson A, Rodriguez M. CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination. J Neuroimmunol. 2007 Aug;188(1-2):13-21.
78. Lipton HL. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun. 1975 May;11(5):1147-1155
79. Cabarrocas J, Bauer J, Piaggio E, Liblau R, Lassmann H. Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol. 2003 May;33(5):1174-1182
80. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol. 2007 Jul;62(1):67-80.
81. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol. 2004 May;5(5):516-523
82. Posner JB. Paraneoplastic syndromes: a brief review. Ann N Y Acad Sci. 1997 Dec 19;835:83-90.
83. Roberts WK, Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol. 2004 Oct;16(5):616-622
84. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002 Sep;1(5):294-305.
85. Bien CG, Bauer J. T-cells in human encephalitis. Neuromolecular Med. 2005;7(3):243-253
86. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998 Oct 5;188(7):1359-1368
87. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998 Mar 5;392(6671): 86-89
88. Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, Wiendl H. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain. 2009 May; 132(Pt 5):1236-1246
89. Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology. 1958 Jun;8(6):435-445
90. Asher DM, Gajdusek DC. Virologic studies in chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Boston: Butterworth-Heineman; 1991. p. 147-158
91. Walter GF, Renella RR. Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet. 1989 Feb 4;1(8632):279-280
92. Power C, Poland SD, Blume WT, Girvin JP, Rice GP. Cytomegalovirus and Rasmussen's encephalitis. Lancet. 1990 Nov 24;336(8726):1282-1284
93. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H. Myelin- specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med. 2009 Jun;15(6):626-632
94. Vogt J, Paul F, Aktas O, MOler-Wielsch K, DOrr J, DOrr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol. 2009 Sep; 66(3):310-322
95. Darabi K, Karulin AY, Boehm BO, Hofstetter HH, Fabry Z, LaManna JC, Chavez JC, Tary-Lehmann M, Lehmann PV. The third signal in T cell-mediated autoimmune disease? J Immunol. 2004 Jul 1; 173(1):92-99
96. McPherson SW, Heuss ND, Roehrich H, Gregerson DS. Bystander killing of neurons by cytotoxic T cells specific for a glial antigen. Glia. 2006 Apr 1; 53(5):457-466
97. Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A, Kuchroo V, Cohen IR, Weiner H, Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001 Jun 1;21(11):3740-3748
98. Schwartz M, Cohen IR. Autoimmunity can benefit self-maintenance. Immunol Today. 2000 Jun;21(6):265-268
99. Kwok LY, Miletic H, Lutjen S, Soltek S, Deckert M, Schluter D. Protective immunosurveillance of the central nervous system by Listeria-specific CD4 and CD8 T cells in systemic listeriosis in the absence of intracerebral Listeria. J Immunol. 2002 Aug 15;169(4):2010-2019